Table 3. Clinical Characteristics of AMI Patients at follow up.
| Basic characteristics | Higher Periostin group | Low Periostin group | P value |
| N | 25 | 25 | – |
| Age (year) | 64.2±12.02 | 62.4±13.69 | 0.624 |
| Male (%) | 80% | 68% | 0.333 |
| Hypertension (%) | 56% | 76% | 0.136 |
| Diabetes mellitus (%) | 36% | 44% | 0.546 |
| Smoking (%) | 52% | 36% | 0.254 |
| Drugs | – | – | – |
| Aspirin | 100% | 100% | – |
| Clopidogrel | 100% | 100% | – |
| ACEI or ARB | 100% | 100% | – |
| Statins | 100% | 100% | – |
| triglyceride (mmol/L) | 1.91±1.22 | 1.53±1.02 | 0.246 |
| cholesterol (mmol/L) | 4.58±1.07 | 4.14±0.97 | 0.139 |
| HDLc (mmol/L) | 0.87±0.2 | 0.98±0.41 | 0.230 |
| LDLc (mmol/L) | 2.50±0.76 | 2.08±0.79 | 0.065 |
| Glucose (mmol/L) | 7.21±3.13 | 6.96±2.41 | 0.751 |
| Cr (umol/L) | 67.79±15.75 | 71.14±22.26 | 0.542 |
| BUN (umol/L) | 6.01±1.71 | 6.46±2.21 | 0.414 |
All determinations were performed in the fasting state.
ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin II receptor antagonists; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; Cr: creatinine; BUN: blood urea nitrogen.
Date presented as mean±SD.